zactima
AZ gets green light for thyroid cancer drug
April 7, 2011Sales and Marketing AstraZeneca, zactima
AstraZeneca’s Zactima has become the first treatment to be approved for a rare form of thyroid cancer. The orphan drug …
Zactima extends progression free survival in other thyroid cancers
September 13, 2010Research and Development thyroid cancer, zactima
New data suggests patients with the more common forms of thyroid cancer respond to AstraZeneca’s Zactima. The drug has already …
Zactima promising in rare thyroid cancer
June 11, 2010Research and Development, Sales and Marketing AstraZeneca, thyroid cancer, zactima
AstraZeneca’s Zactima (vandetanib) will be filed with regulators later this year as a treatment for thyroid cancer after promising results. …
AstraZeneca withdraws filings for lung cancer drug
November 2, 2009Research and Development, Sales and Marketing AZ, zactima
AstraZeneca has withdrawn marketing applications for its lung cancer drug Zactima in Europe and the US after evaluating updated results …
Latest content
Five Facts about NHS and primary care
September 5, 2026
AI in pharma: From lab development to patient impact
September 5, 2026
